[go: up one dir, main page]

Westlund et al., 1982 - Google Patents

Effect of EACA, PAMBA, AMCA and AMBOCA on fibrinolysis induced by streptokinase, urokinase and tissue activator

Westlund et al., 1982

Document ID
2049786315662176729
Author
Westlund L
Lundén R
Wallén P
Publication year
Publication venue
Pathophysiology of Haemostasis and Thrombosis

External Links

Snippet

A study is presented in which the inhibiting effects of EACA, PAMBA, AMCA and AMBOCA on fibrinolysis induced by three activators have been compared by a clot lysis method. The order of inhibitory potency was AMBOCA> AMCA> PAMBA> EACA. The activity ratios …
Continue reading at karger.com (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors

Similar Documents

Publication Publication Date Title
Nilsson et al. Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor.
Teger-Nilsson et al. Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate
Ødegård et al. Heparin cofactor activity measured with an amidolytic method
Collen On the regulation and control of fibrinolysis
Marder et al. High molecular weight derivatives of human fibrinogen produced by plasmin: II. Mechanism of their anticoagulant activity
Harpel Studies on human plasma α2-macroglobulin-enzyme interactions: evidence for proteolytic modification of the subunit chain structure
Vaziri et al. Coagulation, fibrinolytic, and inhibitory proteins in acute myocardial infarction and angina pectoris
Glas-Greenwalt et al. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus
US5994140A (en) Stable coagulation controls
Epstein et al. Radioimmunoassays for protein C and factor X: Plasma antigen levels in abnormal hemostatic states
Kirchhof et al. The determination of prothrombin using synthetic chromogenic substrates; choice of a suitable activator
Kluft et al. alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.
EP0094720B1 (en) Process for assaying the activity of tissue plasminogen activator, and kit suitable for use in said process
Clark et al. Effects of recombinant erythropoietin on murine megakaryocytic colony formation in vitro
Geratz et al. The inhibition of urokinase by aromatic diamidines
Hedner et al. Demonstration of low content of fibrinolytic inhibitors in individuals with high fibrinolytic capacity
Saksela et al. Plasminogen activators, activation inhibitors and alpha2‐macroglobulin produced by cultured normal and malignant human cells
Nilsson et al. Different types of plasminogen activator inhibitors in plasma and platelets in pregnant women
Westlund et al. Effect of EACA, PAMBA, AMCA and AMBOCA on fibrinolysis induced by streptokinase, urokinase and tissue activator
Fareed et al. Diagnostic efficacy of newer synthetic-substrates methods for assessing coagulation variables: a critical overview.
Muller et al. Effect of a moderate fish intake on haemostatic parameters in healthy males
Robbins The human plasma fibrinolytic system: regulation and control
Weinstein et al. Species specificity of the fibrinolytic effects of activated protein C
Seya et al. Generation of C3d, g and C3d by urokinase-treated plasma in association with fibrinolysis
EP0324027A4 (en) Improved assays for t-plasminogen activator and plasminogen activator inhibitor